Affordable Ozempic Launched in India; Novo Nordisk Warns Against Self-Medication

• Ozempic, a diabetes and weight-loss drug, has been launched in India by Novo Nordisk at an affordable price.
• A four-week pen of Ozempic costs ₹8,800 (including tax), with a weekly cost of ₹2,200.
• The drug will be available in local stores soon, offered in 0.25mg, 0.5mg, and 1mg doses.
• Ozempic is approved for Type-2 diabetes, while Novo Nordisk's Wegovy is specifically for obesity.
• Novo Nordisk warns against self-medication with Ozempic, emphasizing it should not be used for weight loss without a doctor's advice.

Why It Matters: Affordable Ozempic for diabetes/obesity in India. Warning: No self-medication.